Duopharma to supply 6.4 million doses of Sputnix V vaccine 


KUALA LUMPUR: Duopharma Biotech Bhd has entered into a deal to supply the Ministry of Health with 6.4 million doses of Covid-19 vaccine developed by Russia.

The supply is subject to the “Sputnik V” vaccine being approved by Drug Control Authority, Malaysia through technical evaluation by the National Pharmaceutical Regulatory Agency.

Unlock 30% Savings on Ad-Free Access Now!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Duopharma Biotech , vaccine , Sputnix V

Next In Business News

Oil prices edge higher as investors assess Iran-Israel ceasefire
Geopolitical tensions abrupt airspace closures keep Malaysian and global airlines on high alert
Ringgit extends gains as Fed signals rate hold
Optimism picks up on Bursa Malaysia after US rally on easing Middle East tensions
Trading ideas: SD Guthrie, IGB REIT, Hektar REIT, Crest Builder, Uni Wall APS, HeiTech Padu, Advancecon, UEM Sunrise, Nestle, Unique, Bonia, Irelia, Peterlabs, Kronologi, AE Multi, Glomac, SSF
Oil falls 6% as Israel-Iran ceasefire cuts Mideast supply risk
Rising ESG adoption augurs well for planters
Ringgit ends higher against the greenback
Uni Wall bags RM90mil building job
Hektar-REIT buys 90% stake in Terramark

Others Also Read